Soros Fund Management - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
Soros Fund Management ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$8,134,000
+46.0%
350,0000.0%0.13%
+42.9%
Q1 2018$5,572,000
-82.1%
350,000
-76.7%
0.09%
-87.2%
Q4 2017$31,170,000
+0.7%
1,500,000
-30.6%
0.71%
-3.1%
Q3 2017$30,953,000
+8.4%
2,160,000
+30.9%
0.74%
+44.9%
Q2 2017$28,545,000
+293.2%
1,650,000
+230.0%
0.51%
+202.4%
Q4 2016$7,260,000
+253.1%
500,000
+5303.1%
0.17%
+784.2%
Q2 2015$2,056,000
-97.6%
9,254
-98.5%
0.02%
-98.0%
Q4 2014$86,809,000
+5.6%
606,587
-3.2%
0.95%
+54.4%
Q3 2014$82,229,000
+38.1%
626,748
+32.7%
0.61%
+36.7%
Q2 2014$59,552,000
+173.1%
472,187
+185.5%
0.45%
+107.9%
Q1 2014$21,806,000165,4110.22%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2023
NameSharesValueWeighting ↓
Bruce & Co., Inc. 850,000$6,987,0002.38%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders